论文信息 - Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110) - 字舞流文

Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)

S. Nicolaou | Hyon K. Choi | P. Traber | T. Kishimoto | W. Dehaan | A. Kivitz | J. Inshaw | E. Sands | L. Johnston | S. Leung | R. Azeem | Justin Park | Sheri Rhodes